𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis

✍ Scribed by WF Carman; C Trautwein; J van Deursen; K Colman; E Dornan; G McIntyre; J Waters; V Kliem; R Müller; HC Thomas; MP Manns

Book ID
118686378
Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
244 KB
Volume
24
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B virus envelope variation aft
Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis
✍ W F Carman; C Trautwein; J van Deursen; K Colman; E Dornan; G McIntyre; J Waters 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 1 views

cleoside analogues, 8-10 the only established treatment option Hepatitis B virus (HBV) replicates via an intermediate to prevent reinfection is the administration of polyclonal hep-RNA step. High frequency of polymerase errors with adatitis B surface antigen antibody (anti-HBs) (hepatitis B imdition

Intramuscular hepatitis B immune globuli
Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation
✍ Yao, Francis Y. ;Osorio, Robert W. ;Roberts, John P. ;Poordad, Fred F. ;Briceno, 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 59 KB

Immunoprophylaxis using intravenous (IV) hepatitis B immune globulin (HBIG) decreases the recurrence of hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT). However, IV HBIG is expensive, has significant side effects, and is inconvenient to administer. An alternative appro

Prophylaxis against hepatitis B recurren
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin
✍ Jay S. Markowitz; Paul Martin; Andrew J. Conrad; James F. Markmann; Philip Seu; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Patients undergoing liver transplantation for hepatitis B-related liver disease are prone to recurrence. The mainstay of prophylaxis has been passive immunotherapy with hepatitis B immune globulin (HBIG). Antiviral therapy with lamivudine has proven effective in lowering hepatitis B virus (HBV) DNA

Hepatitis B virus with antigenically alt
Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation
✍ Ulrike Protzer-Knolle; Uta Naumann; Ralph Bartenschlager; Thomas Berg; Uwe Hopf; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

"Escape" variants of hepatitis B virus (HBV) can cause infection despite previous immunization. These viruses show alterations of the immunogenic major hydrophilic loop of the HBV small surface protein (s-protein). We studied whether HBV "escape" variants were selected in patients with graft infecti